{
    "title": "GlaxoSmith-Kline investors unmoved as drug-maker says it regrets 'shameful' allegations of China corruption",
    "url": "https://www.dailymail.co.uk/money/markets/article-2364319/GlaxoSmith-Kline-concerned-Chinese-corruption.html",
    "date": "2013-07-15",
    "keywords": [
        "gsk",
        "bribery",
        "travel",
        "corruption",
        "money",
        "investigation",
        "drugmaker",
        "july",
        "glaxosmithkline",
        "firm",
        "company",
        "price",
        "agency",
        "use",
        "review",
        "behaviour",
        "mail",
        "gmt",
        "email",
        "view",
        "ministry",
        "security",
        "china",
        "head",
        "unit",
        "organisation",
        "boss",
        "case",
        "bossfeng",
        "campaign",
        "period",
        "base",
        "rate",
        "dividend",
        "income",
        "importance",
        "asset",
        "allocation",
        "basket",
        "flatfee",
        "share",
        "guide",
        "way",
        "mark",
        "country",
        "feng",
        "june",
        "claim",
        "business",
        "london",
        "authoritiesfeng",
        "evidence",
        "sir",
        "andrew",
        "witty",
        "investigationthe",
        "ftse",
        "party",
        "stop",
        "probe",
        "compliance",
        "chinawe",
        "misconduct",
        "thirdparty",
        "tolerance",
        "nature"
    ],
    "category": [
        "money",
        "markets"
    ]
}